Suchergebnisse - "Chou, Cheng-Yang"

PubPharm (7)

1

Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression

enthalten in: Cell death & disease | 2019

von Wu, Y. | Huang, Y. | Chen, C. | +1

2

Case report : term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix

enthalten in: BMC women's health | 2017

von Wu, P. | Cheng, Y. | New, G. | +4

3

COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization

enthalten in: Oncotarget | 2015

von Wu, Y. | Chang, T. | Huang, Y. | +2

4

Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study

enthalten in: Taiwanese journal of obstetrics & gynecology | 2015

von Wang, P. | Sun, H. | Lin, H. | +21

5

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells

enthalten in: Oncotarget | 2015

von Chiu, W. | Huang, Y. | Tsai, H. | +5

6

Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours : a Taiwanese Gynecologic Oncology Group study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2014

von Chen, C. | Lin, H. | Weng, C. | +8

7

Cell fate regulation by gelsolin in human gynecologic cancers

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2014

von Abedini, M. | Wang, P. | Huang, Y. | +4

ErratumIn: Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17684

1
[1]